Abstract
Summary
LPI (LP Information)' newest research report, the “Targeted Drug Delivery System Industry Forecast” looks at past sales and reviews total world Targeted Drug Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drug Delivery System sales for 2023 through 2029. With Targeted Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drug Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drug Delivery System.
The global Targeted Drug Delivery System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Drug Delivery System players cover 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis BiOthersapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc and Novartis Pharmaceuticals Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drug Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nano Tubes
Nano Wires
Nano Shells
Quantum Dots
Nano Pros
Segmentation by application
First Order Targeting (Organ Compartmentalization)
Second Order Targeting (Cellular Targeting)
Third Order Targeting (Intracellular Targeting)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
This Insight Report provides a comprehensive analysis of the global Targeted Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drug Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drug Delivery System.
The global Targeted Drug Delivery System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Drug Delivery System players cover 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis BiOthersapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc and Novartis Pharmaceuticals Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drug Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nano Tubes
Nano Wires
Nano Shells
Quantum Dots
Nano Pros
Segmentation by application
First Order Targeting (Organ Compartmentalization)
Second Order Targeting (Cellular Targeting)
Third Order Targeting (Intracellular Targeting)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Drug Delivery System Market Size 2018-2029
2.1.2 Targeted Drug Delivery System Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Targeted Drug Delivery System Segment by Type
2.2.1 Nano Tubes
2.2.2 Nano Wires
2.2.3 Nano Shells
2.2.4 Quantum Dots
2.2.5 Nano Pros
2.3 Targeted Drug Delivery System Market Size by Type
2.3.1 Targeted Drug Delivery System Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Targeted Drug Delivery System Market Size Market Share by Type (2018-2023)
2.4 Targeted Drug Delivery System Segment by Application
2.4.1 First Order Targeting (Organ Compartmentalization)
2.4.2 Second Order Targeting (Cellular Targeting)
2.4.3 Third Order Targeting (Intracellular Targeting)
2.5 Targeted Drug Delivery System Market Size by Application
2.5.1 Targeted Drug Delivery System Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Targeted Drug Delivery System Market Size Market Share by Application (2018-2023)
3 Targeted Drug Delivery System Market Size by Player
3.1 Targeted Drug Delivery System Market Size Market Share by Players
3.1.1 Global Targeted Drug Delivery System Revenue by Players (2018-2023)
3.1.2 Global Targeted Drug Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Drug Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted Drug Delivery System by Regions
4.1 Targeted Drug Delivery System Market Size by Regions (2018-2023)
4.2 Americas Targeted Drug Delivery System Market Size Growth (2018-2023)
4.3 APAC Targeted Drug Delivery System Market Size Growth (2018-2023)
4.4 Europe Targeted Drug Delivery System Market Size Growth (2018-2023)
4.5 Middle East & Africa Targeted Drug Delivery System Market Size Growth (2018-2023)
5 Americas
5.1 Americas Targeted Drug Delivery System Market Size by Country (2018-2023)
5.2 Americas Targeted Drug Delivery System Market Size by Type (2018-2023)
5.3 Americas Targeted Drug Delivery System Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drug Delivery System Market Size by Region (2018-2023)
6.2 APAC Targeted Drug Delivery System Market Size by Type (2018-2023)
6.3 APAC Targeted Drug Delivery System Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted Drug Delivery System by Country (2018-2023)
7.2 Europe Targeted Drug Delivery System Market Size by Type (2018-2023)
7.3 Europe Targeted Drug Delivery System Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted Drug Delivery System by Region (2018-2023)
8.2 Middle East & Africa Targeted Drug Delivery System Market Size by Type (2018-2023)
8.3 Middle East & Africa Targeted Drug Delivery System Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted Drug Delivery System Market Forecast
10.1 Global Targeted Drug Delivery System Forecast by Regions (2024-2029)
10.1.1 Global Targeted Drug Delivery System Forecast by Regions (2024-2029)
10.1.2 Americas Targeted Drug Delivery System Forecast
10.1.3 APAC Targeted Drug Delivery System Forecast
10.1.4 Europe Targeted Drug Delivery System Forecast
10.1.5 Middle East & Africa Targeted Drug Delivery System Forecast
10.2 Americas Targeted Drug Delivery System Forecast by Country (2024-2029)
10.2.1 United States Targeted Drug Delivery System Market Forecast
10.2.2 Canada Targeted Drug Delivery System Market Forecast
10.2.3 Mexico Targeted Drug Delivery System Market Forecast
10.2.4 Brazil Targeted Drug Delivery System Market Forecast
10.3 APAC Targeted Drug Delivery System Forecast by Region (2024-2029)
10.3.1 China Targeted Drug Delivery System Market Forecast
10.3.2 Japan Targeted Drug Delivery System Market Forecast
10.3.3 Korea Targeted Drug Delivery System Market Forecast
10.3.4 Southeast Asia Targeted Drug Delivery System Market Forecast
10.3.5 India Targeted Drug Delivery System Market Forecast
10.3.6 Australia Targeted Drug Delivery System Market Forecast
10.4 Europe Targeted Drug Delivery System Forecast by Country (2024-2029)
10.4.1 Germany Targeted Drug Delivery System Market Forecast
10.4.2 France Targeted Drug Delivery System Market Forecast
10.4.3 UK Targeted Drug Delivery System Market Forecast
10.4.4 Italy Targeted Drug Delivery System Market Forecast
10.4.5 Russia Targeted Drug Delivery System Market Forecast
10.5 Middle East & Africa Targeted Drug Delivery System Forecast by Region (2024-2029)
10.5.1 Egypt Targeted Drug Delivery System Market Forecast
10.5.2 South Africa Targeted Drug Delivery System Market Forecast
10.5.3 Israel Targeted Drug Delivery System Market Forecast
10.5.4 Turkey Targeted Drug Delivery System Market Forecast
10.5.5 GCC Countries Targeted Drug Delivery System Market Forecast
10.6 Global Targeted Drug Delivery System Forecast by Type (2024-2029)
10.7 Global Targeted Drug Delivery System Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 3M Company
11.1.1 3M Company Company Information
11.1.2 3M Company Targeted Drug Delivery System Product Offered
11.1.3 3M Company Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 3M Company Main Business Overview
11.1.5 3M Company Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Targeted Drug Delivery System Product Offered
11.2.3 Abbott Laboratories Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Ablynx NV
11.3.1 Ablynx NV Company Information
11.3.2 Ablynx NV Targeted Drug Delivery System Product Offered
11.3.3 Ablynx NV Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Ablynx NV Main Business Overview
11.3.5 Ablynx NV Latest Developments
11.4 Aciont Inc
11.4.1 Aciont Inc Company Information
11.4.2 Aciont Inc Targeted Drug Delivery System Product Offered
11.4.3 Aciont Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Aciont Inc Main Business Overview
11.4.5 Aciont Inc Latest Developments
11.5 Acrux
11.5.1 Acrux Company Information
11.5.2 Acrux Targeted Drug Delivery System Product Offered
11.5.3 Acrux Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Acrux Main Business Overview
11.5.5 Acrux Latest Developments
11.6 Agilis BiOthersapeutics LLC
11.6.1 Agilis BiOthersapeutics LLC Company Information
11.6.2 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Product Offered
11.6.3 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Agilis BiOthersapeutics LLC Main Business Overview
11.6.5 Agilis BiOthersapeutics LLC Latest Developments
11.7 Aileron Therapeutics Inc
11.7.1 Aileron Therapeutics Inc Company Information
11.7.2 Aileron Therapeutics Inc Targeted Drug Delivery System Product Offered
11.7.3 Aileron Therapeutics Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aileron Therapeutics Inc Main Business Overview
11.7.5 Aileron Therapeutics Inc Latest Developments
11.8 Nano Precision Medical Inc
11.8.1 Nano Precision Medical Inc Company Information
11.8.2 Nano Precision Medical Inc Targeted Drug Delivery System Product Offered
11.8.3 Nano Precision Medical Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Nano Precision Medical Inc Main Business Overview
11.8.5 Nano Precision Medical Inc Latest Developments
11.9 Novartis Pharmaceuticals Corp
11.9.1 Novartis Pharmaceuticals Corp Company Information
11.9.2 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Product Offered
11.9.3 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Novartis Pharmaceuticals Corp Main Business Overview
11.9.5 Novartis Pharmaceuticals Corp Latest Developments
11.10 Oxford Biomedica
11.10.1 Oxford Biomedica Company Information
11.10.2 Oxford Biomedica Targeted Drug Delivery System Product Offered
11.10.3 Oxford Biomedica Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Oxford Biomedica Main Business Overview
11.10.5 Oxford Biomedica Latest Developments
11.11 PharmaIN Corp
11.11.1 PharmaIN Corp Company Information
11.11.2 PharmaIN Corp Targeted Drug Delivery System Product Offered
11.11.3 PharmaIN Corp Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 PharmaIN Corp Main Business Overview
11.11.5 PharmaIN Corp Latest Developments
11.12 PolyMicrospheres
11.12.1 PolyMicrospheres Company Information
11.12.2 PolyMicrospheres Targeted Drug Delivery System Product Offered
11.12.3 PolyMicrospheres Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 PolyMicrospheres Main Business Overview
11.12.5 PolyMicrospheres Latest Developments
11.13 Presage Biosciences Inc
11.13.1 Presage Biosciences Inc Company Information
11.13.2 Presage Biosciences Inc Targeted Drug Delivery System Product Offered
11.13.3 Presage Biosciences Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Presage Biosciences Inc Main Business Overview
11.13.5 Presage Biosciences Inc Latest Developments
11.14 Pulmatrix Inc
11.14.1 Pulmatrix Inc Company Information
11.14.2 Pulmatrix Inc Targeted Drug Delivery System Product Offered
11.14.3 Pulmatrix Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Pulmatrix Inc Main Business Overview
11.14.5 Pulmatrix Inc Latest Developments
11.15 Quark Pharmaceuticals Inc
11.15.1 Quark Pharmaceuticals Inc Company Information
11.15.2 Quark Pharmaceuticals Inc Targeted Drug Delivery System Product Offered
11.15.3 Quark Pharmaceuticals Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Quark Pharmaceuticals Inc Main Business Overview
11.15.5 Quark Pharmaceuticals Inc Latest Developments
11.16 RegeneRx Biopharmaceuticals Inc
11.16.1 RegeneRx Biopharmaceuticals Inc Company Information
11.16.2 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Product Offered
11.16.3 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 RegeneRx Biopharmaceuticals Inc Main Business Overview
11.16.5 RegeneRx Biopharmaceuticals Inc Latest Developments
11.17 Replicor Inc
11.17.1 Replicor Inc Company Information
11.17.2 Replicor Inc Targeted Drug Delivery System Product Offered
11.17.3 Replicor Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Replicor Inc Main Business Overview
11.17.5 Replicor Inc Latest Developments
11.18 Rexahn Pharmaceuticals Inc
11.18.1 Rexahn Pharmaceuticals Inc Company Information
11.18.2 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Product Offered
11.18.3 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Rexahn Pharmaceuticals Inc Main Business Overview
11.18.5 Rexahn Pharmaceuticals Inc Latest Developments
11.19 Roche Holding AG
11.19.1 Roche Holding AG Company Information
11.19.2 Roche Holding AG Targeted Drug Delivery System Product Offered
11.19.3 Roche Holding AG Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Roche Holding AG Main Business Overview
11.19.5 Roche Holding AG Latest Developments
11.20 Savara Inc
11.20.1 Savara Inc Company Information
11.20.2 Savara Inc Targeted Drug Delivery System Product Offered
11.20.3 Savara Inc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Savara Inc Main Business Overview
11.20.5 Savara Inc Latest Developments
11.21 Serina Therapeutics Inc.
11.21.1 Serina Therapeutics Inc. Company Information
11.21.2 Serina Therapeutics Inc. Targeted Drug Delivery System Product Offered
11.21.3 Serina Therapeutics Inc. Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Serina Therapeutics Inc. Main Business Overview
11.21.5 Serina Therapeutics Inc. Latest Developments
11.22 Silenseed Ltd.
11.22.1 Silenseed Ltd. Company Information
11.22.2 Silenseed Ltd. Targeted Drug Delivery System Product Offered
11.22.3 Silenseed Ltd. Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Silenseed Ltd. Main Business Overview
11.22.5 Silenseed Ltd. Latest Developments
11.23 SoluBest Ltd
11.23.1 SoluBest Ltd Company Information
11.23.2 SoluBest Ltd Targeted Drug Delivery System Product Offered
11.23.3 SoluBest Ltd Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 SoluBest Ltd Main Business Overview
11.23.5 SoluBest Ltd Latest Developments
11.24 Suda Ltd
11.24.1 Suda Ltd Company Information
11.24.2 Suda Ltd Targeted Drug Delivery System Product Offered
11.24.3 Suda Ltd Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Suda Ltd Main Business Overview
11.24.5 Suda Ltd Latest Developments
11.25 Taiwan Liposome Co. Ltd.
11.25.1 Taiwan Liposome Co. Ltd. Company Information
11.25.2 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Product Offered
11.25.3 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Taiwan Liposome Co. Ltd. Main Business Overview
11.25.5 Taiwan Liposome Co. Ltd. Latest Developments
11.26 Pipeline
11.26.1 Pipeline Company Information
11.26.2 Pipeline Targeted Drug Delivery System Product Offered
11.26.3 Pipeline Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Pipeline Main Business Overview
11.26.5 Pipeline Latest Developments
11.27 Vect-Horus S.A.S.
11.27.1 Vect-Horus S.A.S. Company Information
11.27.2 Vect-Horus S.A.S. Targeted Drug Delivery System Product Offered
11.27.3 Vect-Horus S.A.S. Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Vect-Horus S.A.S. Main Business Overview
11.27.5 Vect-Horus S.A.S. Latest Developments
11.28 Vectura Group plc
11.28.1 Vectura Group plc Company Information
11.28.2 Vectura Group plc Targeted Drug Delivery System Product Offered
11.28.3 Vectura Group plc Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Vectura Group plc Main Business Overview
11.28.5 Vectura Group plc Latest Developments
11.29 WAVE Life Sciences Pvt. Ltd.
11.29.1 WAVE Life Sciences Pvt. Ltd. Company Information
11.29.2 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Product Offered
11.29.3 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 WAVE Life Sciences Pvt. Ltd. Main Business Overview
11.29.5 WAVE Life Sciences Pvt. Ltd. Latest Developments
11.30 Xigen SA
11.30.1 Xigen SA Company Information
11.30.2 Xigen SA Targeted Drug Delivery System Product Offered
11.30.3 Xigen SA Targeted Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.30.4 Xigen SA Main Business Overview
11.30.5 Xigen SA Latest Developments
12 Research Findings and Conclusion